159 related articles for article (PubMed ID: 2523922)
21. Effects of PAF antagonist, BN52021, on the PAF-, methacholine-, and allergen-induced bronchoconstriction in asthmatic children.
Hsieh KH
Chest; 1991 Apr; 99(4):877-82. PubMed ID: 2009789
[TBL] [Abstract][Full Text] [Related]
22. The interaction between PAF, platelets and eosinophils in bronchial asthma.
Page CP; Coyle AJ
Eur Respir J Suppl; 1989 Jun; 6():483s-487s. PubMed ID: 2679601
[TBL] [Abstract][Full Text] [Related]
23. Role of platelet-activating factor (PAF) in platelet accumulation in rabbit skin: effect of the novel long-acting PAF antagonist, UK-74,505.
Pons F; Rossi AG; Norman KE; Williams TJ; Nourshargh S
Br J Pharmacol; 1993 May; 109(1):234-42. PubMed ID: 8495241
[TBL] [Abstract][Full Text] [Related]
24. Triggering by Paf-acether and adrenaline of cyclo-oxygenase-independent platelet aggregation.
Fouque F; Vargaftig BB
Br J Pharmacol; 1984 Nov; 83(3):625-33. PubMed ID: 6439269
[TBL] [Abstract][Full Text] [Related]
25. Does acute experimental pancreatitis affect blood platelet function?
Lukaszyk A; Bodzenta-Lukaszyk A; Gabryelewicz A; Bielawiec M
Thromb Res; 1989 Feb; 53(3):319-25. PubMed ID: 2524119
[TBL] [Abstract][Full Text] [Related]
26. Effect of the platelet-activating factor antagonist UK-74,505 on the early and late response to allergen.
Kuitert LM; Hui KP; Uthayarkumar S; Burke W; Newland AC; Uden S; Barnes NC
Am Rev Respir Dis; 1993 Jan; 147(1):82-6. PubMed ID: 8420437
[TBL] [Abstract][Full Text] [Related]
27. [Effect of long-term administration of platelet activating factor on pulmonary response and morphology in the guinea pig].
Mencia-Huerta JM; Touvay C; Pfister A; Braquet P
Allerg Immunol (Paris); 1988 Dec; 22 Suppl 10():21, 23-4. PubMed ID: 3245884
[TBL] [Abstract][Full Text] [Related]
28. [Effect of PAF (platelet-activating factor) on hemostasis. Studies on endothelial cells and platelets].
Rotllan E; Escolar G; Ordinas A; Bastida E
Sangre (Barc); 1993 Apr; 38(2):115-9. PubMed ID: 8390724
[TBL] [Abstract][Full Text] [Related]
29. The evidence of platelet activation in bronchial asthma.
Yamamoto H; Nagata M; Tabe K; Kimura I; Kiuchi H; Sakamoto Y; Yamamoto K; Dohi Y
J Allergy Clin Immunol; 1993 Jan; 91(1 Pt 1):79-87. PubMed ID: 8423274
[TBL] [Abstract][Full Text] [Related]
30. Platelet activating factor does not cause a reproducible increase in bronchial responsiveness in normal man.
Spencer DA; Green SE; Evans JM; Piper PJ; Costello JF
Clin Exp Allergy; 1990 Sep; 20(5):525-32. PubMed ID: 2253083
[TBL] [Abstract][Full Text] [Related]
31. Interactions of the alkyl-ether-phospholipid, platelet activating factor (PAF) with platelets, neural cells, and the psychotropic drugs triazolobenzodiazepines.
Kornecki E; Lenox RH; Hardwick DH; Bergdahl JA; Ehrlich YH
Adv Exp Med Biol; 1987; 221():477-88. PubMed ID: 2893525
[TBL] [Abstract][Full Text] [Related]
32. No increase in plasma histamine during PAF-induced airway obstruction in allergic asthmatics.
Louis R; Bury T; Corhay JL; Radermecker M
Chest; 1993 Sep; 104(3):806-10. PubMed ID: 8365293
[TBL] [Abstract][Full Text] [Related]
33. Platelet role in pathogenesis of atopic and nonimmunologic asthma.
Astafieva NG
Allergol Immunopathol (Madr); 1990; 18(1):19-26. PubMed ID: 2166427
[TBL] [Abstract][Full Text] [Related]
34. Inflammatory mediators of asthma.
Page CP; Sanjar S; Alvemini D; Morley J
Eur J Respir Dis Suppl; 1986; 144():163-89. PubMed ID: 3527737
[No Abstract] [Full Text] [Related]
35. Short-term and long-term role of platelet activating factor as a mediator of in vivo platelet aggregation.
Golino P; Ambrosio G; Ragni M; Pascucci I; Triggiani M; Oriente A; McNatt J; Buja LM; Condorelli M; Chiariello M
Circulation; 1993 Sep; 88(3):1205-14. PubMed ID: 8353882
[TBL] [Abstract][Full Text] [Related]
36. Effects of prostacyclin on bronchoconstriction and neutropenia induced by inhaled platelet-activating factor in man.
Lammers JW; Kioumis I; McCusker M; Nichol GM; Barnes PJ; Chung KF
J Allergy Clin Immunol; 1990 Apr; 85(4):763-9. PubMed ID: 2109002
[TBL] [Abstract][Full Text] [Related]
37. Platelet activating factor in pulmonary pathobiology.
McManus LM; Deavers SI
Clin Chest Med; 1989 Mar; 10(1):107-18. PubMed ID: 2650961
[TBL] [Abstract][Full Text] [Related]
38. [Analysis of platelet-activating factor and its effect on the lung].
Maki N; Kanda Y; Suzuki T; Miyauchi K; Wada Y; Johnston JM
Rinsho Byori; 1993 Feb; 41(2):160-9. PubMed ID: 8361018
[TBL] [Abstract][Full Text] [Related]
39. Acute effects of intratracheal administration of platelet-activating factor in baboons.
Denjean A; Arnoux B; Masse R; Lockhart A; Benveniste J
J Appl Physiol Respir Environ Exerc Physiol; 1983 Sep; 55(3):799-804. PubMed ID: 6629917
[TBL] [Abstract][Full Text] [Related]
40. PAF-dependent phosphatidylinositol turnover in platelets: differences between asthmatics and normal individuals.
Block LH; Imhof E; Emmons LR; Roth M; Perruchoud AP
Respiration; 1990; 57(6):372-8. PubMed ID: 2099571
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
